Other Global Option Considerations. (a) The Global Development and Commercialization License Agreement shall include Lilly’s right to take over the Manufacturing responsibilities for the relevant Product(s) in the expanded Territory and/or original Territory under terms to be negotiated and mutually agreed upon by the Parties. (b) For those countries in the expanded Territory that accept Regulatory Approval documentation from China, Xxxxxxxxx will provide Lilly with such regulatory documentation and dossiers and provide reasonable support to Lilly in its interactions with Regulatory authorities within the expanded Territory countries.
Appears in 4 contracts
Samples: Option Agreement (Hutchison China MediTech LTD), Option Agreement (Hutchison China MediTech LTD), Option Agreement (Hutchison China MediTech LTD)